Delivery Order SPE2DB20D3101-SPE2DB22FQSX3
Award Date 8/26/22
Potential Completion Date 8/29/22
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML to the Defense Logistics Agency (DLA). The contract, valued at $1,787.22, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 19, 2024. This award is not associated with any set-aside designation, indicating open competition....
- This federal contract award is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $3,750.93. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 20, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation is for the delivery of Ofloxacin 0.3% ear drops. The $3,047.55 firm fixed price delivery order contract has an ultimate completion date of June 10, 2025. Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is the prime contractor for this delivery order, which is not designated as a set-aside. The contract is part of a larger $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OFLOXACIN 0.3% EAR DROPS 5ML. The $5,469.25 firm fixed-price delivery order has an ultimate completion date of January 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This federal contract award is for the delivery of 4566353556 - OFLOXACIN 0.3% EAR DROPS 10ML, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,494.05 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) on November 6, 2024, with a completion date of November 7, 2024. The contract is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp,...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order with a Firm Fixed Price of $1,796.37 for the supply of OFLOXACIN 0.3% EAR DROPS 5ML. The contract is awarded by the Medical Supply Chain, which is an alternate name for the Defense Logistics Agency (DLA), a civilian agency. The contract has an ultimate completion date of May 16, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- The federal contract award is for the delivery of Ofloxacin 0.3% ear drops, 10ml, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a pharmaceutical distribution company that serves as a key supplier of medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract has a ceiling value of $3,411.61 and is a delivery order under an Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML, a pharmaceutical product, with a ceiling value of $3,486.18. The contract was awarded on September 27, 2022, with a completion date of September 28, 2022, and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award is for the delivery of Ofloxacin 0.3% ear drops, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 9, 2022, with a ceiling value of $3,509.19 and a completion date of December 12, 2022. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (the parent company of...
- This federal contract award, valued at $3,793.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OFLOXACIN 0.3% EAR DROPS 5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of February 18, 2025. No set-aside designation was used for this award. In addition to this specific delivery order, AmerisourceBergen holds a significant Indefinite...